Rauh Susanne S, Baudin Pierre-Yves, Stojkovic Tanya, Birnbaum Simone, Decostre Valérie, Zanfongnon Rachida-Lydie, Fromes Yves, Hooijmans Melissa T, Strijkers Gustav J, Hogrel Jean-Yves, Olivier Sophie, Marty Benjamin, Reyngoudt Harmen
Institute of Myology, Neuromuscular Investigation Center, NMR Laboratory, Paris, France.
Amsterdam Movement Sciences, Musculoskeletal Health, Amsterdam, The Netherlands.
PLoS One. 2025 Apr 28;20(4):e0321463. doi: 10.1371/journal.pone.0321463. eCollection 2025.
Limb-girdle muscular dystrophy R9 (LGMD-R9) is a rare neuromuscular disease with no curative treatment. Sensitive non-invasive biomarkers are necessary to monitor disease progression and evaluate the efficacy of novel therapies. Here, we investigated several quantitative MRI parameters as suitable biomarkers for evaluating disease progression in LGMD-R9.
Bilateral quantitative MRI of the lower limbs was performed in individuals with LGMD-R9 and healthy controls. Quantitative thigh and leg muscle MRI, functional tests (including time-up-and-go (TUG) and time-to-climb-4-stairs (4S climb)), and muscle strength tests were performed in individuals with LGMD-R9 at baseline, 1-year, and 2-years. qMRI included assessment of muscle fat fraction (FF), water T2, water T1, intramuscular pH from 1H MR spectroscopy, and diffusion tensor imaging (DTI) parameters. Differences between LGMD-R9 and controls, over time, and the relationship between baseline water T1 and water T2 parameters and disease progression (FF, functional and strength parameters) were assessed by linear mixed models and correlation analyses.
18 individuals with LGMD-R9 and 13 controls were enrolled. At baseline, elevated FF, water T2, water T1, and pH were observed in LGMD-R9 (p < 0.05). No differences between controls and LGMD-R9 were found in the DTI parameters. An overall tendency to an increase in FF and a decrease in functional measures were observed over 2 years. However, the changes did not reach significance (p = 0.057-0.752). Baseline water T1 and baseline water T2 correlated with the increase in FF (ΔFF) and change in TUG (ΔTUG) and 4S climb (Δ4S climb) over 2 years (correlation coefficient ≥ 0.6, p < 0.05). No correlation with the strength measures was found.
Our findings suggest that FF, water T2, water T1, and pH are effective biomarkers for LGMD-R9. The correlation of water T2 and water T1 with ΔFF, ΔTUG, and Δ4S climb suggests their potential in predicting disease progression.
肢带型肌营养不良症R9(LGMD - R9)是一种罕见的神经肌肉疾病,目前尚无治愈方法。敏感的非侵入性生物标志物对于监测疾病进展和评估新疗法的疗效至关重要。在此,我们研究了几种定量MRI参数作为评估LGMD - R9疾病进展的合适生物标志物。
对LGMD - R9患者和健康对照者进行双下肢定量MRI检查。在基线、1年和2年时,对LGMD - R9患者进行大腿和小腿肌肉的定量MRI、功能测试(包括起立行走试验(TUG)和爬4级楼梯试验(4S climb))以及肌肉力量测试。定量MRI包括评估肌肉脂肪分数(FF)、水T2、水T1、1H磁共振波谱法测定的肌肉内pH值以及扩散张量成像(DTI)参数。通过线性混合模型和相关性分析评估LGMD - R9患者与对照者之间、随时间的差异以及基线水T1和水T2参数与疾病进展(FF、功能和力量参数)之间的关系。
纳入了18例LGMD - R9患者和13例对照者。在基线时,LGMD - R9患者的FF、水T2、水T1和pH值升高(p < 0.05)。在DTI参数方面,对照者与LGMD - R9患者之间未发现差异。在2年期间观察到FF总体呈上升趋势,功能指标总体呈下降趋势。然而,这些变化未达到显著水平(p = 0.057 - 0.752)。基线水T1和基线水T2与2年期间FF的增加(ΔFF)以及TUG(ΔTUG)和4S climb(Δ4S climb)的变化相关(相关系数≥0.6,p < 0.05)。未发现与力量指标相关。
我们的研究结果表明,FF、水T2、水T1和pH是LGMD - R9的有效生物标志物。水T2和水T1与ΔFF、ΔTUG和Δ4S climb的相关性表明它们在预测疾病进展方面具有潜力。